Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis. [electronic resource]
Producer: 20090402Description: 518-24 p. digitalISSN:- 1524-4636
- Administration, Oral
- Amidines -- administration & dosage
- Angioplasty, Balloon -- adverse effects
- Animals
- Carbamates -- administration & dosage
- Carotid Artery, Common -- drug effects
- Carotid Stenosis -- etiology
- Cell Line
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cholesterol, Dietary -- administration & dosage
- Disease Models, Animal
- Extracellular Matrix -- metabolism
- Humans
- Hyperplasia
- Leukotriene Antagonists -- administration & dosage
- Leukotriene B4 -- metabolism
- Macrophages -- drug effects
- Male
- Mammary Arteries -- metabolism
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Muscle, Smooth, Vascular -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Organ Culture Techniques
- RNA Interference
- RNA, Small Interfering -- metabolism
- Rabbits
- Secondary Prevention
- Stents
- Time Factors
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.